Genprex Strengthens Diabetes Gene Therapy Program with License of Additional Technology from University of Pittsburgh – Yahoo Finance
Technology for modulating autoimmunity expands intellectual property portfolio AUSTIN, Texas , Dec. 15, 2022 /PRNewswire/ — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing…